Connor Iapoce is an associate editor for HCPLive and joined the MJH Life Sciences team in April 2021. He graduated from The College of New Jersey with a degree in Journalism and Professional Writing. He enjoys listening to records, going to concerts, and playing with his cat Squish. You can reach him at ciapoce@mjhlifesciences.com.
Study Investigators Discuss the Evolving Role of ChatGPT in Ophthalmology
August 11th 2023New study data indicate the growing knowledge of artificial intelligence chatbots in ophthalmology. We are joined by 3 study investigators to discuss what this could mean for the field overall and its impact on patient care.
Read More
Retina Specialists Examine Avacincaptad Pegol for Geographic Atrophy
August 8th 2023Last week's FDA approval of avacincaptad pegol marked the second approved treatment for geographic atrophy in 2023. Here, 4 retina specialists discuss the complement inhibitor and what it could represent for patients with GA.
Read More
Paul Hahn, MD: A Cross-Trial Comparison of Pegcetacoplan and Avacincaptad Pegol
July 31st 2023Dr. Hahn discusses an anchored matching-adjusted indirect comparison in patients with geographic atrophy, suggesting a greater reduction in observed lesion growth with monthly pegcetacoplan versus avacincaptad pegol.
Read More
Daily Soft Drink Consumption Increases Obesity, Overweight Rates in Adolescents
July 27th 2023A cross-sectional analysis of more than 100 countries and regions revealed a statistically significant association between the prevalence of daily soft drink consumption and the prevalence of overweight and obesity.
Read More
Liraglutide Could Improve Weight Loss after Poor Response to Metabolic Surgery
July 26th 2023The BARI-OPTIMISE randomized clinical trial reports individuals with poor weight loss after metabolic surgery had significantly greater reductions in body weight after treatment with 3.0 mg liraglutide, compared with placebo.
Read More